Eleonora Allocati

531 total citations
20 papers, 154 citations indexed

About

Eleonora Allocati is a scholar working on Immunology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eleonora Allocati has authored 20 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Economics and Econometrics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eleonora Allocati's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Biosimilars and Bioanalytical Methods (6 papers) and Pharmaceutical Economics and Policy (5 papers). Eleonora Allocati is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Biosimilars and Bioanalytical Methods (6 papers) and Pharmaceutical Economics and Policy (5 papers). Eleonora Allocati collaborates with scholars based in Italy, United Kingdom and South Africa. Eleonora Allocati's co-authors include Brian Godman, Rita Banzi, Silvio Garattini, Marco Gobbi, Chiara Gerardi, Attilio Guarini, Carla Minoia, Evelien Moorkens, Marten Beeg and Vitaliana De Sanctis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Obesity Reviews.

In The Last Decade

Eleonora Allocati

18 papers receiving 149 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleonora Allocati Italy 7 59 49 27 26 25 20 154
Youngdoe Kim South Korea 9 148 2.5× 31 0.6× 50 1.9× 51 2.0× 5 0.2× 23 226
Catherine Parker United States 8 51 0.9× 17 0.3× 10 0.4× 14 0.5× 21 0.8× 13 224
Gabriela Sousa Portugal 8 16 0.3× 32 0.7× 12 0.4× 5 0.2× 20 0.8× 35 163
Paulo Caldeira Portugal 10 56 0.9× 13 0.3× 15 0.6× 6 0.2× 10 0.4× 19 246
J. M. P. A. van den Reek Netherlands 11 346 5.9× 93 1.9× 70 2.6× 9 0.3× 38 1.5× 32 424
Rita Poon United States 6 44 0.7× 34 0.7× 5 0.2× 10 0.4× 7 0.3× 8 231
Anna Gimigliano Italy 5 23 0.4× 85 1.7× 8 0.3× 10 0.4× 15 0.6× 8 270
Johann Poetzl United Kingdom 8 299 5.1× 123 2.5× 128 4.7× 46 1.8× 14 0.6× 15 337
JoAnn Zell United States 7 50 0.8× 11 0.2× 5 0.2× 20 0.8× 47 1.9× 15 249
Q. Li United States 6 318 5.4× 21 0.4× 13 0.5× 12 0.5× 65 2.6× 20 367

Countries citing papers authored by Eleonora Allocati

Since Specialization
Citations

This map shows the geographic impact of Eleonora Allocati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Allocati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Allocati more than expected).

Fields of papers citing papers by Eleonora Allocati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Allocati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Allocati. The network helps show where Eleonora Allocati may publish in the future.

Co-authorship network of co-authors of Eleonora Allocati

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Allocati. A scholar is included among the top collaborators of Eleonora Allocati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Allocati. Eleonora Allocati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrano, Francesco Maria, Eleonora Allocati, Rita Banzi, et al.. (2025). Surgery and Minimally Invasive Devices for the Treatment of Obesity in Children and Adolescents: A Systematic Review and Meta‐Analysis. Obesity Reviews. 26(12). e13974–e13974.
2.
Montori, Giulia, Monica Ortenzi, Chiara Gerardi, et al.. (2024). Systematic review and meta-analysis of the use of high-energy devices for thyroid surgery. Langenbeck s Archives of Surgery. 409(1).
3.
Ortenzi, Monica, Ferdinando Agresta, Nereo Vettoretto, et al.. (2023). Use of High Energy Devices (HEDs) versus electrocautery for laparoscopic cholecystectomy: a systematic review and meta-analysis of randomised controlled trials. Surgical Endoscopy. 37(6). 4249–4269. 2 indexed citations
4.
Nassi, Luca, Vitaliana De Sanctis, Giacomo Loseto, et al.. (2022). Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi. Cancers. 14(3). 519–519. 5 indexed citations
5.
Allocati, Eleonora, Brian Godman, Marco Gobbi, Silvio Garattini, & Rita Banzi. (2022). Switching Among Biosimilars: A Review of Clinical Evidence. Frontiers in Pharmacology. 13. 917814–917814. 24 indexed citations
6.
7.
8.
Beeg, Marten, Eleonora Allocati, Clorinda Ciafardini, et al.. (2021). Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera. Scientific Reports. 11(1). 14976–14976. 19 indexed citations
9.
Beeg, Marten, Eleonora Allocati, & Marco Gobbi. (2021). A Surface Plasmon Resonance-Based Assay for Simultaneous Measurement of Serum Concentrations of Therapeutic Antibodies and Anti-Drug Antibodies. Methods in molecular biology. 2313. 323–336. 2 indexed citations
10.
Marković‐Peković, Vanda, et al.. (2021). Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications. SHILAP Revista de lepidopterología. 5. 3888122604–3888122604. 8 indexed citations
11.
Godman, Brian, Joseph Fadare, Hye-Young Kwon, et al.. (2021). Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research. 10(12). 1019–1052. 32 indexed citations
12.
Gerardi, Chiara, Eleonora Allocati, Carla Minoia, Attilio Guarini, & Rita Banzi. (2021). Long-Term Follow-Up of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: Aims and Methodological Approach for Fondazione Italiana Linfomi Systematic Reviews. Cancers. 13(12). 2976–2976. 4 indexed citations
13.
Franceschetti, Silvia, Maria Antonietta Annunziata, Chiara Gerardi, et al.. (2021). Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi. Cancers. 13(14). 3401–3401. 6 indexed citations
14.
15.
16.
Viviani, Simonetta, Chiara Gerardi, Safaa Ramadan, et al.. (2021). Male and Female Fertility: Prevention and Monitoring Hodgkin’ Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors. A Systematic Review by the Fondazione Italiana Linfomi. Cancers. 13(12). 2881–2881. 11 indexed citations
17.
Allocati, Eleonora, Vittorio Bertelè, Chiara Gerardi, Silvio Garattini, & Rita Banzi. (2020). Clinical evidence supporting the marketing authorization of biosimilars in Europe. European Journal of Clinical Pharmacology. 76(4). 557–566. 6 indexed citations
18.
Allocati, Eleonora & Brian Godman. (2020). Key patient related factors in the management of inflammatory bowel disease. Journal of Medical Economics. 23(12). 1606–1609. 1 indexed citations
19.
Godman, Brian, Eleonora Allocati, Evelien Moorkens, & Hye-Young Kwon. (2020). Can local policies on biosimilars optimize the use of freed resources – experiences from Italy. Generics and Biosimilars Initiative Journal. 9(4). 183–187. 5 indexed citations
20.
Godman, Brian, Eleonora Allocati, & Evelien Moorkens. (2019). Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective. Generics and Biosimilars Initiative Journal. 8(3). 93–97. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youngdoe Kim Breakdown of academic impact, for papers by Catherine Parker Breakdown of academic impact, for papers by Gabriela Sousa Breakdown of academic impact, for papers by Paulo Caldeira Breakdown of academic impact, for papers by J. M. P. A. van den Reek Breakdown of academic impact, for papers by Rita Poon Breakdown of academic impact, for papers by Anna Gimigliano Breakdown of academic impact, for papers by Johann Poetzl Breakdown of academic impact, for papers by JoAnn Zell Breakdown of academic impact, for papers by Q. Li
Rankless by CCL
2026